| DAY 1 | Auditorium 1 | Auditorium 2 | Auditorium 3 | Auditorium 4 | ELRIG Tech Theatre - supported by DDW | Learning Zone | |
| 08:00 |
Registration |
|
|
|
|
|
08:00 |
| 08:05 |
|
|
|
|
08:05 |
| 08:10 |
|
|
|
|
08:10 |
| 08:15 |
|
|
|
|
08:15 |
| 08:20 |
|
|
|
|
08:20 |
| 08:25 |
|
|
|
|
08:25 |
| 08:30 |
|
|
|
|
08:30 |
| 08:35 |
|
|
|
|
08:35 |
| 08:40 |
|
|
|
|
08:40 |
| 08:45 |
|
|
|
|
|
08:45 |
| 08:50 |
|
|
|
|
|
08:50 |
| 08:55 |
|
|
|
|
|
08:55 |
| 09:00 |
|
|
|
|
|
09:00 |
| 09:05 |
|
|
|
|
|
09:05 |
| 09:10 |
|
|
|
|
|
|
09:10 |
| 09:15 |
|
|
|
|
|
09:15 |
| 09:20 |
|
|
|
|
|
09:20 |
| 09:25 |
|
|
|
|
|
09:25 |
| 09:30 |
|
|
|
|
|
|
09:30 |
| 09:35 |
New technologies for the design and characterisation of nanotechnology mediated therapeutics
09:35 (45 mins)
Molly Stevens, Imperial College London
|
|
|
|
|
|
09:35 |
| 09:40 |
|
|
|
|
|
09:40 |
| 09:45 |
|
|
|
|
|
09:45 |
| 09:50 |
|
|
|
|
|
09:50 |
| 09:55 |
|
|
|
|
|
09:55 |
| 10:00 |
|
|
|
|
|
10:00 |
| 10:05 |
|
|
|
|
|
10:05 |
| 10:10 |
|
|
|
|
|
10:10 |
| 10:15 |
|
|
|
|
|
10:15 |
| 10:20 |
Refreshment Break |
|
|
|
|
|
10:20 |
| 10:25 |
|
|
|
10:25 |
| 10:30 |
|
|
|
10:30 |
| 10:35 |
|
|
|
10:35 |
| 10:40 |
|
|
|
|
|
10:40 |
| 10:45 |
|
|
|
|
|
10:45 |
| 10:50 |
|
|
|
|
|
10:50 |
| 10:55 |
|
|
|
|
|
10:55 |
| 11:00 |
|
|
|
|
|
11:00 |
| 11:05 |
Session Introduction
11:05 (5 mins)
Sian Lewis, MSD Michael Howell, The Francis Crick Institute
High Content Imaging as an enabling tool for early drug discovery
11:10 (30 mins)
John Bassett, MSD
Accelerating Drug Discovery with Cell Painting
12:10 (30 mins)
James Pilling, AstraZeneca
|
Session Introduction
11:05 (5 mins)
Allan Jordan, Sygnature Discovery Sarah Skerrat, CHARM Therapeutics
Discovery and validation of in vitro and in vivo probes for human DNA Polymerase theta (Polθ)
11:10 (30 mins)
Robert Heald, Artios Pharma
The COVID Moonshot – from open science collaboration in fragment screening to drug candidate and beyond to Pandemic Preparedness
11:40 (30 mins)
Ed Griffen, MedChemica Ltd
ML/AI: Opportunities, Impact and Future Directions in Drug Design
12:10 (30 mins)
Sarah Skerrat, CHARM Therapeutics
|
Session Introduction
11:05 (5 mins)
Chris Herring, Adaptimmune Claire Dobson, AstraZeneca
TCR Evolution, revolution: How Adaptimmune is developing innovative TCR T-cell therapies to treat solid tumors
11:10 (30 mins)
Jo Brewer, Adaptimmune Limited
From Stem-Cells to T-Cells: Next-Generation DNA NanoVectors -an Alternative Non-Integrating DNA Vector Platform for
Regenerative Medicine and Immunotherapy
12:10 (30 mins)
Richard Harbottle, German Cancer Research Centre (DKFZ)
|
Session Introduction
11:05 (5 mins)
Anna Morgan, Physiology & Pharmacology, Kingston University Simon Pitchford, King's College London
The burden of unmet needs in COPD
11:10 (30 mins)
Wisia Wedzicha, Imperial College London
Novel drug targets in COPD
11:40 (30 mins)
Ian Adcock, Imperial College London
Use of Imaging for preclinical evaluation of drugs for the treatment of COPD
12:15 (30 mins)
Anna Morgan, Physiology & Pharmacology, Kingston University
|
|
|
11:05 |
| 11:10 |
|
|
11:10 |
| 11:15 |
|
|
11:15 |
| 11:20 |
|
|
11:20 |
| 11:25 |
|
|
11:25 |
| 11:30 |
|
|
11:30 |
| 11:35 |
|
|
11:35 |
| 11:40 |
|
|
11:40 |
| 11:45 |
|
|
11:45 |
| 11:50 |
|
|
11:50 |
| 11:55 |
|
|
11:55 |
| 12:00 |
|
|
12:00 |
| 12:05 |
|
|
12:05 |
| 12:10 |
|
|
12:10 |
| 12:15 |
|
|
12:15 |
| 12:20 |
|
|
12:20 |
| 12:25 |
|
|
12:25 |
| 12:30 |
|
|
12:30 |
| 12:35 |
|
|
12:35 |
| 12:40 |
|
|
12:40 |
| 12:45 |
Refreshment Break - Poster Session 13.15 - 13.45 |
|
|
|
|
|
12:45 |
| 12:50 |
|
|
|
12:50 |
| 12:55 |
|
|
|
12:55 |
| 13:00 |
|
|
|
13:00 |
| 13:05 |
|
|
|
|
13:05 |
| 13:10 |
|
|
|
|
13:10 |
| 13:15 |
|
|
|
|
13:15 |
| 13:20 |
|
|
|
|
13:20 |
| 13:25 |
|
|
|
13:25 |
| 13:30 |
|
|
|
13:30 |
| 13:35 |
|
|
|
13:35 |
| 13:40 |
|
|
|
|
13:40 |
| 13:45 |
|
|
|
|
|
13:45 |
| 13:50 |
|
|
|
|
|
13:50 |
| 13:55 |
|
|
|
|
|
13:55 |
| 14:00 |
Phenonaut; a tool for multiomic data integration, analysis, prediction, and inference
14:00 (30 mins)
Steven Shave, University of Edinburgh & GSK
Life beyond the pixels: single-cell analysis using deep learning and image analysis methods
14:40 (30 mins)
Peter Horvath, Biological Research Centre, Szeged
|
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery - Design tips and tricks
14:00 (30 mins)
Jamie Scott, AstraZeneca
New Approaches to the Synthesis and Application of DNA-Encoded Libraries
14:35 (30 mins)
Jessica Graham, Newcastle University Harriet Stanway-Gordon, Newcastle University
|
Pin-point™ – A Modular Base Editing System Driving Cell and Gene therapies
14:00 (30 mins)
Michael Anbar, Horizon Discovery, a PerkinElmer company
Armouring CAR-T cells therapy against the immunosuppressive microenvironment in solid tumour
14:40 (30 mins)
Romain Lara, AstraZeneca
|
Preclinical translational models for investigating drugs for the treatment of COPD
14:00 (30 mins)
Simon Pitchford, King's College London
Use of human tissues to investigate drugs for the treatment of COPD
14:30 (30 mins)
Luigino Calzetta, University of Parma
|
|
|
14:00 |
| 14:05 |
|
|
14:05 |
| 14:10 |
|
|
14:10 |
| 14:15 |
|
|
14:15 |
| 14:20 |
|
14:20 |
| 14:25 |
|
14:25 |
| 14:30 |
|
14:30 |
| 14:35 |
|
14:35 |
| 14:40 |
|
14:40 |
| 14:45 |
|
14:45 |
| 14:50 |
|
14:50 |
| 14:55 |
|
14:55 |
| 15:00 |
|
|
15:00 |
| 15:05 |
|
|
15:05 |
| 15:10 |
Refreshment Break |
|
|
|
|
|
15:10 |
| 15:15 |
|
|
|
|
|
15:15 |
| 15:20 |
|
|
|
15:20 |
| 15:25 |
|
|
|
15:25 |
| 15:30 |
|
|
|
15:30 |
| 15:35 |
|
|
|
|
|
15:35 |
| 15:40 |
|
|
|
|
|
15:40 |
| 15:45 |
Morphological trajectory inference: Tracking cell state transitions and the impact of small-molecule perturbations
15:45 (30 mins)
Rebecca Hughes, University of Edinburgh
Quantitative high-throughput screening of single cancer cell phenotypes in 3D matrices
16:30 (30 mins)
Vicky Bousgouni, Institute of Cancer Research
|
Targeting the template: A novel therapeutic strategy for prion diseases
15:45 (30 mins)
Heulyn Jones, Cardiff University
Audience Lead Panel Discussion with Q&A
16:30 (30 mins)
Allan Jordan, Sygnature Discovery Sarah Skerrat, CHARM Therapeutics
|
Unlocking a revolutionary class of in vivo reprogramming therapies through systematic, unbiased identification of the key cell switches controlling cell fate
15:45 (30 mins)
Louise Modis, Mogrify
Next Generation Platforms for Human Gene Therapy
16:30 (30 mins)
Aravind Asokan, Duke University
|
Early experimental medicine studies for investigating new drugs for COPD
15:45 (30 mins)
Dave Singh, University of Manchester
Publishing in the British Journal of Pharmacology
16:30 (30 mins)
Charles Whalley, British Pharmacological Society
|
|
|
15:45 |
| 15:50 |
|
|
15:50 |
| 15:55 |
|
|
15:55 |
| 16:00 |
|
|
16:00 |
| 16:05 |
|
|
16:05 |
| 16:10 |
|
|
16:10 |
| 16:15 |
|
|
16:15 |
| 16:20 |
|
|
16:20 |
| 16:25 |
|
|
16:25 |
| 16:30 |
|
|
16:30 |
| 16:35 |
|
|
16:35 |
| 16:40 |
|
|
16:40 |
| 16:45 |
|
|
16:45 |
| 16:50 |
|
|
16:50 |
| 16:55 |
|
|
16:55 |
| 17:00 |
|
|
|
|
|
|
17:00 |
| 17:05 |
|
|
|
|
|
17:05 |
| 17:10 |
|
|
|
|
|
17:10 |
| 17:15 |
|
|
|
|
|
17:15 |
| 17:20 |
|
|
|
|
17:20 |
| 17:25 |
|
|
|
|
17:25 |
| 17:30 |
|
|
|
|
17:30 |
| 17:35 |
|
|
|
|
17:35 |
| 17:40 |
|
|
|
|
17:40 |
| 17:45 |
|
|
|
|
17:45 |
| 17:50 |
|
|
|
|
17:50 |
| 17:55 |
|
|
|
|
17:55 |
| 18:00 |
|
|
|
|
18:00 |
| 18:05 |
|
|
|
|
18:05 |
| 18:10 |
|
|
|
|
18:10 |
| 18:15 |
|
|
|
|
|
18:15 |
| 18:20 |
|
|
|
|
|
18:20 |
| 18:25 |
|
|
|
|
|
18:25 |
| 18:30 |
|
|
|
|
|
18:30 |
| 18:35 |
|
|
|
|
|
18:35 |
| 18:40 |
|
|
|
|
|
18:40 |
| 18:45 |
|
|
|
|
|
18:45 |
| 18:50 |
|
|
|
|
|
18:50 |
| 18:55 |
|
|
|
|
|
18:55 |
| 19:00 |
|
|
|
|
|
|
19:00 |
Print